Name: Prodrug ACE Inhibitors
Creator: Stephen H. Rabinowitz
Keywords: 03 medical and health sciences, 0302 clinical medicine, Humans, Angiotensin-Converting Enzyme Inhibitors, Prodrugs, Biotransformation, 3. Good health

descriptionPublicationkeyboard_double_arrow_right Article 24 Nov 1998 English Publisher:Ovid Technologies (Wolters Kluwer Health)Journal:Circulation, volume 98, pages 2,358-2,359 (issn: 0009-7322, eissn: 1524-4539,

Authors: Stephen H. Rabinowitz;

doi: 10.1161/01.cir.98.21.2358

pmid: 9826330

Prodrug ACE Inhibitors

- Summary
- Subjects
- Metrics

Abstract

To the Editor: In a recent issue of Circulation , Brown and Vaughan1 reviewed ACE inhibitors. They stated that captopril and lisinopril are active drugs and listed 7 other ACE inhibitors approved in the United States that are inactive prodrugs until metabolized in the liver. More information should be provided on this clinically important subject. First, the package …

Related Organizations

North Shore University Hospital
United States
Northwell Health
United States

Keywords

Humans, Angiotensin-Converting Enzyme Inhibitors, Prodrugs, Biotransformation

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	1
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average